NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Moderna To $165? Plus This Analyst Cuts PT On FedEx

Published 08/09/2022, 14:46
Updated 08/09/2022, 15:41
© Reuters.  Moderna To $165? Plus This Analyst Cuts PT On FedEx
FDX
-
IXIC
-
TGTB34
-
FDXB34
-
M1RN34
-

  • Deutsche Bank (ETR:DBKGn) raised the price target on Moderna , Inc. (NASDAQ: NASDAQ:MRNA) from $155 to $165. Deutsche Bank analyst Emmanuel Papadakis also upgraded the stock from Hold to Buy. Moderna shares rose 2.8% to trade at $138.70 on Thursday.
  • Wedbush lowered the price target for Verint Systems Inc. (NASDAQ: VRNT) from $65 to $56. Wedbush analyst Daniel Ives maintained the stock with a Outperform. Verint shares fell 9.9% to $40.94 on Thursday.
  • Wells Fargo (NYSE:WFC) reduced the price target on Toast, Inc. (NYSE: TOST) from $27 to $23. Toast shares rose 0.5% to $19.18 in pre-market trading.
  • Wells Fargo cut the price target for FedEx Corporation (NYSE: NYSE:FDX) from $282 to $269. FedEx shares fell 1.2% to $199.23 on Thursday.
  • Citigroup (NYSE:C) cut the price target on American Eagle Outfitters , Inc. (NYSE: NYSE:AEO) from $13 to $10. American Eagle shares fell 11.5% to $10.26 in pre-market trading.
  • Goldman Sachs (NYSE:GS) boosted the price target for Enphase Energy, Inc. (NASDAQ: ENPH) from $290 to $328. Enphase Energy shares rose 1.8% to $321.84 on Thursday.
  • Stifel raised the price target on Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) from $60 to $65. Apellis Pharmaceuticals shares jumped 1.7% to $65.32 on Thursday.
Check out this: Volatility In Markets Decreases After Dow Surges Over 400 Points

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.